v3.25.2
Condensed Consolidated Statements Of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (13,103,847) $ (5,731,364)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,252,744 1,588,564
Share based compensation 53,276 185,723
Credit loss provision (19,316) 65,864
Fair value remeasurement of earnout consideration   (800,000)
Fair value remeasurement of warrant liability 7,531,044 (461,022)
Fair value remeasurement of embedded derivative liability   1,055,600
Fair value remeasurement of contingent forward contract (899,080)  
Fair value remeasurement of contingent value rights (25,450) (492,860)
Loss on extinguishment of debt 343,471  
Gain on sale of assets   (6,118)
Interest and accretion expense 212,592 1,500,503
Changes in assets and liabilities:    
Trade accounts receivable 1,601,897 202,476
Inventories 385,677 327,540
Income taxes (20,847) (69,971)
Other assets, net 534,878 (264,877)
Accounts payable (489,960) 822,503
Accrued compensation and benefits 403,470 (436,080)
Customer deposits (336,485) (774,524)
Other accrued liabilities (323,130) 758,737
Accrued interest (634,467) (896,420)
Net cash used in operating activities (3,533,533) (3,425,726)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Capital expenditures (8,817) (17,579)
Proceeds from the sale of property, plant and equipment   6,118
Net cash used in investing activities (8,817) (11,461)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Payments against loans payable (8,514,664) (748,647)
Payments against related party loans payable (1,038,279)  
Payments related to debt issuance costs (38,613)  
Payments related to equity issuance costs (2,128,038) (81,012)
Proceeds from the issuance of common stock and pre-funded warrants under registered direct offering 9,690,790 1,000,000
Proceeds from the issuance of common stock on the exercise of pre-funded warrants 11,078  
Proceeds from the issuance of Series A and Series B warrants 10,298,134  
Proceeds from the issuance of common stock under at-the-market offering 351,372  
Proceeds from the issuance of Series B preferred stock   15
Payments for the termination of Series A warrants (267,391)  
Proceeds from issuance of common stock, net of shares withheld   9,773
Cash in lieu payment on fractional shares under reverse stock split   (1,132)
Payment of contingent consideration related to acquisition (2,500,000)  
Purchase of common stock   (6,098)
Net cash provided by financing activities 5,864,389 172,899
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH 2,322,039 (3,264,288)
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD 1,151,348 5,396,343
CASH, CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD 3,473,387 2,132,055
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:    
Income taxes paid 49,698 69,500
Interest paid 1,139,593 821,306
SUPPLEMENTAL DISCLOSURES OF NON-CASH ACTIVITIES:    
Issuance of common stock for the settlement of loss contingencies $ 880,756  
Deemed dividend on Convertible Preferred Stock and PIPE Warrants   11,322,639
Conversion of redeemable convertible preferred stock to common stock   $ 15,277,055

Source